1,057 results on '"Tien, Hwei-Fang"'
Search Results
2. Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis
3. Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
4. Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients
5. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
6. Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations
7. Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome
8. An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia
9. Epidemiology, Treatment Outcomes, and Prognosis of Myelodysplastic Syndromes/Neoplasms in Taiwan: Real-World Insights and Trends
10. Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
11. Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target
12. Multicolour and lineage-specific interphase chromosome Flow-FISH: method development and clinical validation
13. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
14. Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy
15. Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
16. Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
17. Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
18. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression
19. Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015
20. Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
21. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
22. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
23. Annotation-free deep learning for predicting gene mutations from whole slide images of acute myeloid leukemia.
24. Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
25. Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma
26. Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
27. Incidence and risk factors for venous thromboembolism in a cohort of Taiwanese patients with lung, gastric, pancreatic cancers or lymphoma
28. Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
29. Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
30. Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015
31. A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
32. Synergistic effect of concurrent high molecular risk mutations and lower JAK2mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study
33. Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
34. Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy.
35. A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
36. Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008–2013
37. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
38. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice
39. Non-del(5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis
40. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials
41. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
42. Influence of TP53gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
43. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
44. A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia
45. An Ensemble Model for Acute Myeloid Leukemia Risk Stratification Recommendations by Combining Machine Learning with Clinical Guidelines
46. Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms
47. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
48. IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
49. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
50. Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.